During the past decade, Glaucoma Consultants and Center for Eye Research, PA conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 3 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Glaucoma Consultants and Center for Eye Research, PA" #1 sponsor was "Santen Inc." with 2 trials, followed by "Aerie Pharmaceuticals" with 1 trials sponsored, "Otsuka Pharmaceutical Development & Commercialization, Inc." with 1 trials sponsored, "Pfizer's Upjohn has merged with Mylan to form Viatris Inc." with 1 trials sponsored and "Rigel Pharmaceuticals" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Glaucoma Consultants and Center for Eye Research, PA" #1 collaborator was "Novartis" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Glaucoma Consultants and Center for Eye Research, PA" are "Keratoconjunctivitis Sicca" (2 trials), "Epilepsies, Partial" (1 trials), "Glaucoma and Ocular Hypertension" (1 trials), "Primary Open Angle Glaucoma or Ocular Hypertension" (1 trials) and "Primary Open-angle Glaucoma and Ocular Hypertension" (1 trials). Many other conditions were trialed in "Glaucoma Consultants and Center for Eye Research, PA" in a lesser frequency.

Most popular intervention types in "Glaucoma Consultants and Center for Eye Research, PA" are "Drug" (6 trials). Other intervention types were less common.

The name of intervention was led by "DE-117 Ophthalmic Solution" (2 trials), "AR-13324 Ophthalmic Solution 0.02%" (1 trials), "AR-13324 Ophthalmic Solution 0.04%" (1 trials), "AR-13324 Ophthalmic Solution Placebo" (1 trials) and "Lyrica (pregabalin)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Glaucoma Consultants and Center for Eye Research, PA" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Glaucoma Consultants and Center for Eye Research, PA". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Glaucoma Consultants and Center for Eye Research, PA, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Glaucoma Consultants and Center for Eye Research, PA, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".